EUREMAP (101131663)
https://cordis.europa.eu/project/id/101131663
Horizon Europe (2021-2027)
European Research Infrastructure for Marine Bioprospecting
Consolidation of the RI landscape – development of complementarities, synergies and/or integration between a set of pan- European research infrastructures (HORIZON-INFRA-2023-DEV-01-04)
drug discovery · bioeconomy
2024-01-01 Start Date (YY-MM-DD)
2026-12-31 End Date (YY-MM-DD)
€ 0
Description
The main objective of the EUREMAP consortium is to optimise the marine bioprospecting pipeline in Europe to enable state-of-the-art research and capacity for both academia and industry. The ambition is to leverage strengths available within European Research Infrastructures (RIs) and to align capacities and resources of the multidisciplinary field of marine bioprospecting. Hence, to increase the competitiveness of marine natural products in the field of drug discovery and to strengthen the blue bioeconomy in Europe, we will assemble a new pipeline that aligns and integrates the existing technical capacities and multidisciplinary expertise of the three European RIs - EU-OPENSCREEN (EU-OS), EMBRC and ELIXIR - in the field of marine natural products discovery. EUREMAP will develop a unique trans-RI integrated service in an European priority area, the blue economy. The pipeline will be an important part of the European blue growth strategy to stimulate economic growth through innovations in marine biotechnology. The potential for innovations and value creation in the blue biotechnology sector is high, and the sector is characterised by being multidisciplinary, knowledge-intensive and built on technology. Building a new European transnational RI service platform to support the competitiveness of an academic and industrial community in all aspects of this multidisciplinary field. EUREMAP will bring together an experienced, multidisciplinary consortium across three RIs to support and enable the discovery of novel bioactive natural products from marine organisms by utilizing novel technology to improve the capacity of European RIs.
Complicit Organisations
1 Israeli organisation participates in EUREMAP.Country | Organisation (ID) | VAT Number | Role | Activity Type | Total Cost | EC Contribution | Net EC Contribution |
---|---|---|---|---|---|---|---|
Norway | UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET (999874643) | nan | coordinator | HES | € 0 | € 973,617 | € 973,617 |
Belgium | UNIVERSITEIT GENT (999986096) | BE0248015142 | participant | HES | € 0 | € 339,504 | € 339,504 |
Germany | EUROPEAN MOLECULAR BIOLOGY LABORATORY (999988230) | nan | participant | REC | € 0 | € 529,342 | € 529,342 |
Italy | STAZIONE ZOOLOGICA ANTON DOHRN (999468310) | IT04894530635 | participant | REC | € 0 | € 227,495 | € 227,495 |
Norway | SINTEF AS (910945140) | nan | participant | REC | € 0 | € 320,647 | € 320,647 |
Italy | CONSIGLIO NAZIONALE DELLE RICERCHE (999979500) | IT02118311006 | participant | REC | € 0 | € 307,182 | € 307,182 |
Portugal | CENTRO DE CIENCIAS DO MAR DO ALGARVE (998611994) | PT506197760 | participant | REC | € 0 | € 455,503 | € 455,503 |
Germany | HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (999470347) | DE114815244 | participant | REC | € 0 | € 315,545 | € 315,545 |
Israel | TEL AVIV UNIVERSITY (999901609) | IL589931187 | participant | HES | € 0 | € 78,995 | € 78,995 |
Spain | FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA (988192060) | ESG18889444 | participant | REC | € 0 | € 522,751 | € 522,751 |
Germany | EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (EU-OPENSCREEN ERIC) (910913033) | nan | participant | REC | € 0 | € 561,244 | € 561,244 |
France | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (999997930) | FR40180089013 | thirdParty | REC | € 0 | € 0 | € 47,243 |
France | SORBONNE UNIVERSITE (909875521) | FR90130023385 | participant | HES | € 0 | € 365,738 | € 318,495 |